180 related articles for article (PubMed ID: 28881355)
1. Presurgical weight loss affects tumour traits and circulating biomarkers in men with prostate cancer.
Demark-Wahnefried W; Rais-Bahrami S; Desmond RA; Gordetsky JB; Hunter GR; Yang ES; Azrad M; Frugé AD; Tsuruta Y; Norian LA; Segal R; Grizzle WE
Br J Cancer; 2017 Oct; 117(9):1303-1313. PubMed ID: 28881355
[TBL] [Abstract][Full Text] [Related]
2. Feasibility outcomes of a presurgical randomized controlled trial exploring the impact of caloric restriction and increased physical activity versus a wait-list control on tumor characteristics and circulating biomarkers in men electing prostatectomy for prostate cancer.
Demark-Wahnefried W; Nix JW; Hunter GR; Rais-Bahrami S; Desmond RA; Chacko B; Morrow CD; Azrad M; Frugé AD; Tsuruta Y; Ptacek T; Tully SA; Segal R; Grizzle WE
BMC Cancer; 2016 Feb; 16():61. PubMed ID: 26850040
[TBL] [Abstract][Full Text] [Related]
3. Randomized trial of weight loss in primary breast cancer: Impact on body composition, circulating biomarkers and tumor characteristics.
Demark-Wahnefried W; Rogers LQ; Gibson JT; Harada S; Frugé AD; Oster RA; Grizzle WE; Norian LA; Yang ES; Della Manna D; Jones LW; Azrad M; Krontiras H
Int J Cancer; 2020 May; 146(10):2784-2796. PubMed ID: 31442303
[TBL] [Abstract][Full Text] [Related]
4. Phase II prospective randomized trial of weight loss prior to radical prostatectomy.
Henning SM; Galet C; Gollapudi K; Byrd JB; Liang P; Li Z; Grogan T; Elashoff D; Magyar CE; Said J; Cohen P; Aronson WJ
Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):212-220. PubMed ID: 29203893
[TBL] [Abstract][Full Text] [Related]
5. Exploring effects of presurgical weight loss among women with stage 0-II breast cancer: protocol for a randomised controlled feasibility trial.
Tsuruta Y; Rogers LQ; Krontiras H; Grizzle WE; Frugé AD; Oster RA; Umphrey HR; Jones LW; Azrad M; Demark-Wahnefried W
BMJ Open; 2016 Sep; 6(9):e012320. PubMed ID: 27633639
[TBL] [Abstract][Full Text] [Related]
6. Exploration of biomarkers from a pilot weight management study for men undergoing radical prostatectomy.
Dimachkie MD; Bechtel MD; Robertson HL; Michel C; Lee EK; Sullivan DK; Chalise P; Thrasher JB; Parker WP; Godwin AK; Pathak HB; DiGiovanni J; Shivappa N; Hébert JR; Hamilton-Reeves JM
Urol Oncol; 2021 Aug; 39(8):495.e7-495.e15. PubMed ID: 33563536
[TBL] [Abstract][Full Text] [Related]
7. A study of caloric restriction versus standard diet in overweight men with newly diagnosed prostate cancer: a randomized controlled trial.
Wright JL; Plymate S; D'Oria-Cameron A; Bain C; Haugk K; Xiao L; Lin DW; Stanford JL; McTiernan A
Prostate; 2013 Sep; 73(12):1345-51. PubMed ID: 23775525
[TBL] [Abstract][Full Text] [Related]
8. Circulating Tumor Cells in Biochemical Recurrence of Prostate Cancer.
Aragon-Ching JB; Siegel RS; Frazier H; Andrawis R; Hendricks F; Phillips M; Jarrett T; Guebre-Xabiher H; Patierno S; Simmens SJ
Clin Genitourin Cancer; 2015 Oct; 13(5):e341-5. PubMed ID: 25956468
[TBL] [Abstract][Full Text] [Related]
9. Protein-Pacing Caloric-Restriction Enhances Body Composition Similarly in Obese Men and Women during Weight Loss and Sustains Efficacy during Long-Term Weight Maintenance.
Arciero PJ; Edmonds R; He F; Ward E; Gumpricht E; Mohr A; Ormsbee MJ; Astrup A
Nutrients; 2016 Jul; 8(8):. PubMed ID: 27483317
[TBL] [Abstract][Full Text] [Related]
10. Low Serum Testosterone But Not Obesity Predicts High Gleason Score at Biopsy Diagnosed as Prostate Cancer in Patients with Serum PSA Lower than 20 ng/ml.
Shiota M; Takeuchi A; Sugimoto M; Dejima T; Kashiwagi E; Kiyoshima K; Inokuchi J; Tatsugami K; Yokomizo A
Anticancer Res; 2015 Nov; 35(11):6137-45. PubMed ID: 26504040
[TBL] [Abstract][Full Text] [Related]
11. Prediagnostic Obesity and Physical Inactivity Are Associated with Shorter Telomere Length in Prostate Stromal Cells.
Joshu CE; Peskoe SB; Heaphy CM; Kenfield SA; Van Blarigan EL; Mucci LA; Giovannucci EL; Stampfer MJ; Yoon G; Lee TK; Hicks JL; De Marzo AM; Meeker AK; Platz EA
Cancer Prev Res (Phila); 2015 Aug; 8(8):737-42. PubMed ID: 25990087
[TBL] [Abstract][Full Text] [Related]
12. Elevated C-Peptides, Abdominal Obesity, and Abnormal Adipokine Profile are Associated With Higher Gleason Scores in Prostate Cancer.
Di Sebastiano KM; Pinthus JH; Duivenvoorden WC; Patterson L; Dubin JA; Mourtzakis M
Prostate; 2017 Feb; 77(2):211-221. PubMed ID: 27699825
[TBL] [Abstract][Full Text] [Related]
13. Epithelial cell adhesion molecule-positive circulating tumor cells as predictive biomarker in patients with prostate cancer.
Amato RJ; Melnikova V; Zhang Y; Liu W; Saxena S; Shah PK; Jensen BT; Torres KE; Davis DW
Urology; 2013 Jun; 81(6):1303-7. PubMed ID: 23622774
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of antioxidant gene expression levels in circulating cancer cell clusters for the detection of prostate cancer in patients with prostate-specific antigen levels of 4-10 ng/mL and disease prognostication after radical prostatectomy.
Giesing M; Suchy B; Driesel G; Molitor D
BJU Int; 2010 Apr; 105(7):1000-10. PubMed ID: 19818074
[TBL] [Abstract][Full Text] [Related]
15. Testosterone Therapy after Radiation Therapy for Low, Intermediate and High Risk Prostate Cancer.
Pastuszak AW; Khanna A; Badhiwala N; Morgentaler A; Hult M; Conners WP; Sarosdy MF; Yang C; Carrion R; Lipshultz LI; Khera M
J Urol; 2015 Nov; 194(5):1271-6. PubMed ID: 26025500
[TBL] [Abstract][Full Text] [Related]
16. Sex hormone-binding globulin is a significant predictor of extracapsular extension in men undergoing radical prostatectomy.
Salonia A; Gallina A; Briganti A; Zanni G; Suardi N; Capitanio U; Colombo R; Bertini R; Freschi M; Guazzoni G; Rigatti P; Montorsi F
BJU Int; 2011 Apr; 107(8):1243-9. PubMed ID: 20883480
[TBL] [Abstract][Full Text] [Related]
17. Dietary Weight Loss and Exercise Effects on Serum Biomarkers of Angiogenesis in Overweight Postmenopausal Women: A Randomized Controlled Trial.
Duggan C; Tapsoba Jde D; Wang CY; McTiernan A
Cancer Res; 2016 Jul; 76(14):4226-35. PubMed ID: 27417562
[TBL] [Abstract][Full Text] [Related]
18. Selective estrogen receptor alpha agonist GTx-758 decreases testosterone with reduced side effects of androgen deprivation therapy in men with advanced prostate cancer.
Yu EY; Getzenberg RH; Coss CC; Gittelman MM; Keane T; Tutrone R; Belkoff L; Given R; Bass J; Chu F; Gambla M; Gaylis F; Bailen J; Hancock ML; Smith J; Dalton JT; Steiner MS
Eur Urol; 2015 Feb; 67(2):334-41. PubMed ID: 24968970
[TBL] [Abstract][Full Text] [Related]
19. Effect of weight loss, with or without exercise, on body composition and sex hormones in postmenopausal women: the SHAPE-2 trial.
van Gemert WA; Schuit AJ; van der Palen J; May AM; Iestra JA; Wittink H; Peeters PH; Monninkhof EM
Breast Cancer Res; 2015 Sep; 17(1):120. PubMed ID: 26330303
[TBL] [Abstract][Full Text] [Related]
20. Serum 17β-estradiol fails as a marker in identification of aggressive tumour disease in patients with localized prostate cancer.
Schnoeller TJ; Steinestel J; Zengerling F; Schrader AJ; Jentzmik F
World J Urol; 2015 Dec; 33(12):1979-84. PubMed ID: 25903805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
